Cerebrovascular Disease in Sickle Cell Anemia patients;Enfermedades Cerebrovasculares en pacientes con Anemia Falciforme

Investigacion Clinica

Volumn 45, Issue 1, 2004, Pages 43-51

  Plumacher, R Zayda ^a   Ferrer Ocando, Olmedo ^b   Arteaga Vizcaíno, Melvis ^b   Weir Medina, Jesús ^a   Ferrer, O Yenny ^b  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Cerebral ischemic; Cerebral Magnetic Resonance; Cerebrovascular disease; Sickle Cell Anemia

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CEREBROVASCULAR DISEASE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; INCIDENCE; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; RADIODIAGNOSIS; SICKLE CELL ANEMIA;

ADOLESCENT; ANEMIA, SICKLE CELL; CEREBROVASCULAR DISORDERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE;

EID: 1942437582     PISSN: 05355133     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Adams R J. Neurologic Complications. In: Embury SH, Hebbel RP, Mohandas N, Steinberg M. Sickle Cell Disease Basic Principles and Clinical Practice. New York. Raven Press. 2nd. Edition. 1994, 599-619.
2. Lane PA. Sickle Cell Disease. Pediatrics Clin of North America, Pediatric Hematology 1996; 42(3): 597-621.
3. Vichinsky E. Comprehensive Care in Sickle Cell Disease: It's Impact on Morbidity and Mortality. Seminars in Hematology 1991; 28(3): 220-226.
4. Perez-Requejo JL. Hematología. 3era. Edición Caracas-Venezuela, Editorial Disinlimed C.A. 1995, p 237-254.
5. Pineda-Del Villar L, Peña J. Hemoglobina S en Islas de Toas: un problema genético de salud pública. Invest Clin 1986; 27: 15-24:
6. Torres-Guerra E, Torres-Guerra T, Valbuena G, Arteaga-Vizcaino M, Soto L. Frecuencia de anemia falciforme en la población de "Cuatro Bocas", Parroquia Ricaurte, Municipio Mara, Estado Zulia, Venezuela. Invest Clin 1993; 34(2): 99-105.
7. Balkaran B, Char G, Morris JS, Thomas Pw, Serjeant BE, Serjeant GR. Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatrics 1992; 120 (3): 360-366.
8. Cohen AR, Martin MB, Silber JH, Kim HC, Ohene Frempong K, Schawartz E. A modified transfusion program for prevention of stroke in sickle cell disease. Blood 1992; 79(7):1657-1661.
9. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DC, Pegelow CH, Gil FM. Cerebrovascular Accidents in Sickle Cell Disease: Rates and Risk Factors. Blood 1998; 91(1): 288-294.
10. Seibert JJ, Miller SF, Kirby RS, Bectron D, James CH, Glasier CM, Wilson AR, Kinder DI, Berry DH. Cerebrovascular Disease in Symptomatic and Asymptomatic Patients with Sickle Cell Anemia: Screening with Duplex Transcranial Doppler US-Correlation with MR Imaging and MR Angiography. Radiology 1993; 189: 457-466.
11. Moser FG, Miller ST, Bello JA, Pegelow CH, Zimmerman R, Wang WC, Ohene-Frempong K, Shwarts A, Vichinsky EP, Gallagher D, Kinney TR. The spectrum of brain MR abnormalities in sickle cell disease: a report from the cooperative study of sickle cell disease. Am J Neuroradiology 1996; 17: 965-972.
12. Miller S, Macklin E, Pegelow CH, Kinney T, Sleeper L, Bello J, De Witt LD, Gallagher DM, Guarini L, Moses FG, Ohene-Fremonp K, Sanchez M, Vichiski EP, Wang W, Wethers DI, Younkin DP, Zimmerman RA, DeBaun MR. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: A report from the Cooperative Study of Sickle Cell Disease. J Pediatr 2001; 139(3): 385-390.
13. Adams RJ, Mckie VC, Hsu L, Files B, Gallagher D, Abdullak K, Gallagher D, Kutlar A, Nichols FT, Bonds D, Brambilla D. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results of transcraneal doppler ultrasonography. N Engl J Med 1998; 339:5-11.
14. Ohene-Frempong K. Stroke in Sickle Cell Disease: Demografic Clinical and Therapeutic Considerations. Seminars in Hematology 1991; 28(3):213-219.
15. Pegelow CH, Adams RJ, Mckie V, Abboud MM, Berman B, Miller S, Olivieri N, Vichinsky E, Wang W, Brandilla D. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatrics 1995; 126 (6): 896-899.
16. Wiznitzer M, Ruggieri P, Masaryk T, Ross J, Modic M, Berman B. Diagnosis of cerebrovascular disease in sickle cell anemia by magnetic resonance angiography. J. Pediatrics 1990; 177: 551-555.
17. Moran CJ, Siegel MJ, Debaun MR. Sickle Cell Disease: Imaging of Cerebrovascular Complications. Radiology 1998; 206(2):
18. Hernández PA. Hemorragia cerebral y crisis hipertensiva. Una propuesta clínica. Invest Clin 2001; 42(4):221-223.
19. Craft S, Schatz J, Glauser TA, Lee B, Debaun MR. Neuropsychologic effects of stroke in children with sickle cell anemia. J Pediatrics 1993; 123(5): 712-717.
20. Schatz J, Brown R, Pascual J, Hsu L, De Baun M. Poor school and cognitive functioning with silent cerebral infarcts and sickle cell disease. Neurology 2001; 56(8): 53-59.
21. Adams R, Mckie V, Nichols F. The use of transcraneal ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992; 326 (10): 605-610.
22. Powars DR, Conti PS, Wong WY, Groney P, Hyman C, Smith E, Ewing N, Keenan RE, Zee CS, Harold Y, Hiti AL, Teng EL Chan LS. Cerebral Vasculopathy in Sickle Cell Anemia: Diagnostic Contribution of Positron Emission Tomography. Blood. 1999; 93 (1): 71-79.
23. Wang WC. Multicenter comparison of magnetic resonance imaging and transcranial doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease. J Pediatr Hematol Oncol 2000; 22(4): 335-339.
24. Ferrer-Ocando O, Plumacher-Rincón Z, Arteaga-Vizcaino M, Weir-Medina J, Hernández-Pernía A. Silent cerebral infarct in patients with sickle cell anemia. Rev Neurol 2002: 35(8): 716-719.
25. Francis RB, Johnson CS. Vascular Occlusion in Sickle Cell Disease: Current Concepts and Unanswered Questions. Blood 1991; 77(7): 1405-1414.
26. nd Ed. New York, NY: Churchill Livingstone, 1992; 859-868.
27. Wang W, Kounar E, Tonkin I, Mulhern R, Langston JW, Day SW. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatrics 1991; 118: 377-382.
28. Pavlakis SG, Bello S, Prohounik J, Sutton M, Ince O, Mohr JP. Brain infarction in sickle cell anemia magnetic resonance imaging correlates. Ann Neurol 1998; 23:125-130.
29. Pavlakis S G. Neurologic complication of sickle cell disease. Adv Pediatr 1989; 36: 247-276.
30. Platt OS, Brambilla D, Rosse W, Milner F, Castro O, Steinberg M, Klug PP. Mortality in sickle cell disease. Life Expectancy and risk factors for early death. N Engl J Mcd 1994; 330: 1639-1643.
31. Adams RJ. Stroke prevention and treatment in sickle cell disease. Arch Neurol 2001; 58(4): 565-568.